Results
|
2541.
|
|
|
2542.
|
Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC). [electronic resource] by
- Molife, L R
- Attard, G
- Fong, P C
- Karavasilis, V
- Reid, A H M
- Patterson, S
- Riggs, C E
- Higano, C
- Stadler, W M
- McCulloch, W
- Dearnaley, D
- Parker, C
- de Bono, J S
Producer: 20100224
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 21
Availability: No items available.
|
|
2543.
|
Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. [electronic resource] by
- Parsons, Ainslie B
- Lopez, Andres
- Givoni, Inmar E
- Williams, David E
- Gray, Christopher A
- Porter, Justin
- Chua, Gordon
- Sopko, Richelle
- Brost, Renee L
- Ho, Cheuk-Hei
- Wang, Jiyi
- Ketela, Troy
- Brenner, Charles
- Brill, Julie A
- Fernandez, G Esteban
- Lorenz, Todd C
- Payne, Gregory S
- Ishihara, Satoru
- Ohya, Yoshikazu
- Andrews, Brenda
- Hughes, Timothy R
- Frey, Brendan J
- Graham, Todd R
- Andersen, Raymond J
- Boone, Charles
Producer: 20060919
In:
Cell vol. 126
Availability: No items available.
|
|
2544.
|
|
|
2545.
|
A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma. [electronic resource] by
- Holkova, Beata
- Yazbeck, Victor
- Kmieciak, Maciej
- Bose, Prithviraj
- Ma, Shuo
- Kimball, Amy
- Tombes, Mary Beth
- Shrader, Ellen
- Wan, Wen
- Weir-Wiggins, Caryn
- Singh, Amanda
- Hogan, Kevin T
- Conine, Sarah
- Sankala, Heidi
- Roberts, John D
- Shea, Thomas C
- Grant, Steven
Producer: 20180112
In:
Leukemia & lymphoma vol. 58
Availability: No items available.
|
|
2546.
|
|
|
2547.
|
|
|
2548.
|
|
|
2549.
|
|
|
2550.
|
|
|
2551.
|
|
|
2552.
|
Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115. [electronic resource] by
- Maroun, J A
- Belanger, K
- Seymour, L
- Matthews, S
- Roach, J
- Dionne, J
- Soulieres, D
- Stewart, D
- Goel, R
- Charpentier, D
- Goss, G
- Tomiak, E
- Yau, J
- Jimeno, J
- Chiritescu, G
Producer: 20070207
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 17
Availability: No items available.
|
|
2553.
|
|
|
2554.
|
|
|
2555.
|
|
|
2556.
|
Suppression of phosphatidylinositol 3-kinase/Akt signaling pathway is a determinant of the sensitivity to a novel histone deacetylase inhibitor, FK228, in lung adenocarcinoma cells. [electronic resource] by
- Kodani, Masahiro
- Igishi, Tadashi
- Matsumoto, Shingo
- Chikumi, Hiroki
- Shigeoka, Yasushi
- Nakanishi, Hirofumi
- Morita, Masato
- Yasuda, Kazuhito
- Hitsuda, Yutaka
- Shimizu, Eiji
Producer: 20050329
In:
Oncology reports vol. 13
Availability: No items available.
|
|
2557.
|
|
|
2558.
|
|
|
2559.
|
|
|
2560.
|
Nobilamides A-H, long-acting transient receptor potential vanilloid-1 (TRPV1) antagonists from mollusk-associated bacteria. [electronic resource] by
- Lin, Zhenjian
- Reilly, Christopher A
- Antemano, Rowena
- Hughen, Ronald W
- Marett, Lenny
- Concepcion, Gisela P
- Haygood, Margo G
- Olivera, Baldomero M
- Light, Alan
- Schmidt, Eric W
Producer: 20110817
In:
Journal of medicinal chemistry vol. 54
Availability: No items available.
|